Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 150NIH 63INDUSTRY 29NETWORK 7FED 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Dermatologic 2

Conditions

Colorectal Neoplasms 33Prostatic Neoplasms 26Neoplasms 22Colonic Neoplasms 12Lung Neoplasms 10Colonic Polyps 10Breast Neoplasms 10Rare Diseases 8Adenoma 6Pulmonary Disease, Chronic Obstructive 5Heart Failure 5Rectal Neoplasms 4Ovarian Neoplasms 4Pain 3Mental Disorders 3Death 3Adenomatous Polyps 3Uterine Cervical Neoplasms 2Urinary Incontinence 2Smoking Cessation 2Skin Neoplasms 2Sezary Syndrome 2Respiratory Aspiration 2Renal Insufficiency, Chronic 2Polycystic Ovary Syndrome 2Patient Preference 2Patient Compliance 2Obesity 2Neurologic Manifestations 2Neurofibromatosis 2 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × FED × Mycosis Fungoides × Clear all
NCT00099593 2015-03-25

Immunization Against Tumor Cells in Sezary Syndrome

FDA Office of Orphan Products Development

Phase 2 Completed
17 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00254332 2015-03-25

Effect of Denileukin Diftitox on Immune System in CTCL Patients

FDA Office of Orphan Products Development

Completed
10 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡